Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/102787
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome |
Author: | Tan, L. Mintoff, C. Johan, M. Ebert, B. Fedele, C. Zhang, Y. Szeto, P. Sheppard, K. McArthur, G. Foster-Smith, E. Ruszkiewicz, A. Brown, M. Bonder, C. Shackleton, M. Ebert, L. |
Citation: | Oncotarget, 2016; 7(29):46492-46508 |
Publisher: | Impact journals |
Issue Date: | 2016 |
ISSN: | 1949-2553 1949-2553 |
Statement of Responsibility: | Lih Yin Tan, Chris Mintoff, M. Zahied Johan, Brenton W. Ebert, Clare Fedele, You Fang Zhang, Pacman Szeto, Karen E. Sheppard, Grant A. McArthur, Erwin Foster-Smith, Andrew Ruszkiewicz, Michael P. Brown, Claudine S. Bonder, Mark Shackleton, Lisa M. Ebert |
Abstract: | Tumors can develop a blood supply not only by promoting angiogenesis but also by forming vessel-like structures directly from tumor cells, known as vasculogenic mimicry (VM). Understanding mechanisms that regulate VM is important, as these might be exploitable to inhibit tumor progression. Here, we reveal the adhesion molecule desmoglein 2 (DSG2) as a novel mediator of VM in melanoma. Analysis of patient-derived melanoma cell lines and tumor tissues, and interrogation of The Cancer Genome Atlas (TCGA) data, revealed that DSG2 is frequently overexpressed in primary and metastatic melanomas compared to normal melanocytes. Notably, this overexpression was associated with poor clinical outcome. DSG2+ melanoma cells self-organized into tube-like structures on Matrigel, indicative of VM activity, which was inhibited by DSG2 knockdown or treatment with a DSG2-blocking peptide. Mechanistic studies revealed that DSG2 regulates adhesion and cell-cell interactions during tube formation, but does not control melanoma cell viability, proliferation or motility. Finally, analysis of patient tumors revealed a correlation between DSG2 expression, VM network density and expression of VM-associated genes. These studies identify DSG2 as a key regulator of VM activity in human melanoma and suggest this molecule might be therapeutically targeted to reduce tumor blood supply and metastatic spread. |
Keywords: | melanoma; desmoglein 2; vasculogenic mimicry; cadherin, TCGA |
Rights: | © All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License. |
DOI: | 10.18632/oncotarget.10216 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1053792 http://purl.org/au-research/grants/nhmrc/1022150 http://purl.org/au-research/grants/nhmrc/1002654 http://purl.org/au-research/grants/nhmrc/1106576 |
Published version: | http://dx.doi.org/10.18632/oncotarget.10216 |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_102787.pdf | Published Version | 8.41 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.